Allspring Global Investments
MXCT icon

Allspring Global Investments’s MaxCyte MXCT Stock Holding History

Allspring Global Investments’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-285,146
Closed -$1.19M – 2486
2024
Q1 		$1.19M Sell
285,146
-5,406
-2% -$25.4K ﹤0.01% 1320
2023
Q4 		$1.37M Sell
290,552
-35,862
-11% -$140K ﹤0.01% 1262
2023
Q3 		$1.02M Sell
326,414
-7,983
-2% -$32.1K ﹤0.01% 1356
2023
Q2 		$1.53M Sell
334,397
-12,990
-4% -$59.7K ﹤0.01% 1311
2023
Q1 		$1.72M Buy
347,387
+7,528
+2% +$37.1K ﹤0.01% 1290
2022
Q4 		$1.86M Buy
339,859
+4,989
+1% +$30.6K ﹤0.01% 1265
2022
Q3 		$2.18M Sell
334,870
-9,135
-3% -$51K ﹤0.01% 1212
2022
Q2 		$1.63M Sell
344,005
-2,187
-0.6% -$10.8K ﹤0.01% 1297
2022
Q1 		$2.42M Buy
346,192
+123,427
+55% +$843K ﹤0.01% 1406
2021
Q4 		$2.27M Buy
+222,765
New +$2.39M ﹤0.01% 1475

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments's MXCT Position: Q2 2024 in Review

Allspring Global Investments sold out of MaxCyte (MXCT) in Q2 2024, closing a stake of 285,146 shares — an estimated $1.19M sold.

Allspring Global Investments first reported a position in MXCT in Q4 2021 and held it in 10 quarters. The position peaked at $2.42M in Q1 2022. 114 funds tracked by Wall St. Rank hold MXCT as of Q2 2024.

  • Allspring Global Investments reported no remaining MaxCyte position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 285,146 MaxCyte shares in Q2 2024, an estimated $1.19M.
  • Allspring Global Investments first reported a position in MaxCyte in Q4 2021 and held it in 10 quarters.
  • Allspring Global Investments's MaxCyte position peaked at $2.42M in Q1 2022.
  • 114 funds tracked by Wall St. Rank held MaxCyte as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.